In This Section


Wednesday, October 6, 2021

Welcome and Opening Session
10 a.m.-12 p.m.

Melissa B. Davis, Weill Cornell Medicine, New York, New York
Tamara L. Lotan, Johns Hopkins University School of Medicine, Baltimore, Maryland
Camille C. R. Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Jose G. Trevino, Virginia Commonwealth University, Richmond, Virginia 

Keynote Address
Health disparity research: The new frontier of research
Robert A. Winn, VCU Massey Cancer Center, Richmond, Virginia

Advocate Keynote
The state of possible
Loriana Hernandez-Aldama, ArmorUp for LIFE, Atlanta, Georgia

AACR Distinguished Lecture
Making progress, together: An inclusive, broad-based approach to reducing excess burden of breast cancer among African American women in St. Louis with lessons for national implementation  
Graham A. Colditz, Washington University School of Medicine, St. Louis, Missouri 

12-12:15 p.m.
Concurrent Sessions 1 & 2
12:15-1:45 p.m.
Concurrent Session 1: Artificial Intelligence for the New Frontier of Cancer Health Disparities Research
Session Chairs: Thomas J. Fuchs, Icahn School of Medicine at Mount Sinai, New York, New york and Gretchen P. Jackson, IBM Watson Health, Franklin, Tennessee

Leveraging the potential of artificial and machine learning technologies to address cancer health disparities
Irene Dankwa-Mullan, IBM Watson Health, Bethesda, Maryland

Artificial intelligence and digital diagnostics for cervical cancer screening in resource-limited settings 
Johan E. Lundin, University of Helsinki, Helsinki, Finland 

Challenges and opportunities in using AI to improve healthcare for the underserved 
Amit Sethi, Indian Institute of Technology Bombay, Mumbai, India 

Panel Discussion

Concurrent Session 2: Cancer Health Disparities in Individuals of Latin American Descent
Session Chair: Laura Fejerman, UC Davis Comprehensive Cancer Center, Davis, CAlifornia

Genetic ancestry and lung cancer somatic mutations in patients of Latin American descent: Etiology and treatment implications
Matthew L. Meyerson, Dana-Farber Cancer Institute, Boston, Massachusetts

Cervical cancer in U.S. Hispanic/Latino populations: Addressing multilevel/multidimensional determinants to eliminate a preventable disparity 
Ana Patricia Ortiz, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico

Liver cancer and differences across Hispanic groups: Importance of disaggregation in understanding cancer disparities
Paulo S. Pinheiro, University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida

Panel Discussion

1:45-2 p.m.
Concurrent Sessions 3 & 4
2-3 p.m.
Concurrent Session 3: Developing Research Tools for Cancer Health Disparities
Session Chairs: Kevin L. Gardner, Vagelos College of Physicians and Surgeons at Columbia University, New York, New York, and Charles M. Perou, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Assembling patient-derived models (PDXs) in minority populations
Luis G. Carvajal-Carmona, University of California Davis, Davis, California

Practical issues and considerations in setting up a biobank
Hanina Hibshoosh, Columbia University, New York, New York

Building organ-specific biobanks in Nigeria: Challenges, benefits, and success strategies
Olusegun Isaac Alatise,  Obafemi Awolowo University, Ile Ife, Nigeria

Panel Discussion

Concurrent Session 4: LGBTQ+ Cancer Health Disparities
Session Chair: Jesse Ehrenfeld, Medical College of Wisconsin, Milwaukee, WIsconsin

Using large, prospective cohort data to elucidate sexual orientation-related cancer disparities
Brittany M. Charlton, Harvard Medical School, Boston, Massachusetts

Findings from Out: The National Cancer Survey
Scout, National LGBT Cancer Network, Providence, Rhode Island

Sex hormones and anal cancer precursor conditions
Dorothy J. Wiley, UCLA School of Nursing, Los Angeles, California

Panel Discussion

3:30-3:45 p.m.
Concurrent Sessions 5 & 6
3:45-5:15 p.m.
Concurrent Session 5: Advancing Cancer Health Disparities Research Globally
Session chair: James R. Alaro, National Cancer Institute, Rockville, Maryland

Global Cancer Health Disparities: A definition proposed by NCI 
James R. Alaro

Why study cancer health disparities globally: US and global perspectives 
Camille C. R. Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Understanding global cancer health disparities: A systems thinking approach 
Peter S. Hovmand, Case Western Reserve University, Cleveland, Ohio

Panel Discussion
Facilitator: Satish Gopal, National Cancer Institute, Rockville, Maryland 

Camille C. R. Ragin
Peter S. Hovmand
CS Pramesh, Tata Memorial Hospital, Mumbai, India 
Martin Lajous, Instituto Nacional de Salud Pública, Ciudad de Mexico, Mexico 

Concurrent Session 6: Heterogeneity Within the Asian and Pacific Islander Diaspora: Focusing on Diversity to Understand Cancer Determinants
Session Chairs: Scarlett L. Gomez, University of California San francisco, San Francisco, CAlifornia, and Grace X. Ma, Temple University, Philadelphia, Pennsylvania

Cancer in Asian American, Native Hawaiians, Pacific Islanders: Epidemiology and sociodemographics overview
Scarlett L. Gomez

The opportunities and challenges of integrating population histories into genetic studies for diverse populations 
Charleston Chiang, University of Southern California, Los Angeles, California

Applying a data integrative and convergence epidemiology approach to study multilevel risk factors for cancer in distinct AANHPI populations 
Mindy DeRouen, University of California San Francisco, San Francisco, California

A multilevel framework for reducing cancer risk in diverse Asian American populations 
Carolyn Fang, Fox Chase Cancer Center, Cheltenham, Pennsylvania 

Panel Discussion

Thursday, October 7, 2021

Addressing Advocacy at the Bench 
8:30–9:30 a.m. 

The Centers for Disease Control (CDC) and Prevention recommends that everyone 12 years and older get a COVID-19 vaccine. That includes most people with underlying medical conditions, including cancer. To date, there are over 80 million Americans who have not been vaccinated. The reasons are numerous, but the leading explanation is mistrust in the vaccine and concern about its long-term effects. This session will address the topic of mistrust of health care providers or systems among underrepresented communities, who are more likely to get seriously ill and die from COVID-19, but hesitant to take the coronavirus vaccine; and highlight ways patient advocates are engaging their communities and building trust in the vaccine. Highlighted programs focused on improving communications, increasing education, creating welcoming environments, and addressing barriers to access.

Plenary Session 1: Addressing Unconscious and Implicit Bias in Clinical Cancer Research and Healthcare
Session Chair: Lauren M. Hamel, Wayne State University School of Medicine, Detroit, Michigan, and Vetta L. Sanders Thompson, Washington University in St. Louis, St. Louis, Missouri 
10-11:30 A.M.

Addressing implicit bias in clinical trial enrollment and faculty hiring 
Lorna H. McNeill, UT MD Anderson Cancer Center, Pearland, Texas

Implicit bias in oncology: Towards a more inclusive workforce 
Jessica W. Tsai, Dana-Farber Cancer Institute, Boston, Massachusetts

Bias and stereotyping in recruiting for cancer clinical trials
Soumya J. Niranjan, University of Alabama at Birmingham, Birmingham, Alabama

Panel Discussion

11:30-11:45 a.m.
Concurrent Sessions 7 & 8
11:45 A.M.-1:15 P.M.
Concurrent Session 7: Cancer Health Disparities Exposome: From the Zip Code to Genetic Code
Session chair: Samson Gebreab, National Institutes of Health, Rockville, Maryland and Sandra L. San Miguel, NCI-CRCHD, Bethesda, Maryland

The exposome: A systematic analysis of the environmental drivers of cancer health disparities  
Gary W. Miller, Columbia University, New York, New York

Uncovering exposome-phenome associations from zip codes to molecules
Chirag J. Patel, Harvard Medical School, Boston, Massachusetts

Exposomics in precision medicine and precision prevention: The time is now!
Rosalind J. Wright, Icahn School of Medicine at Mount Sinai, New York, New York

Liver cancer in the context of DOHAD: The role of imprinting dysregulation
Cathrine Hoyo, North Carolina State University, Raleigh, North Carolina

Panel Discussion 

Concurrent Session 8: Cancer Health Disparities in the African American/Black Community and the African Diaspora
Session Chairs: Sophia H. I. George, University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, and Camille C. R. Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania

The landscape of endometrial cancer in women of African descent
Matthew Schlumbrecht, Sylvester Comprehensive Cancer Center, Miami, Florida

Racial disparities in colon cancer: Epigenetics and the microbiome 
Carmen Sapienza, Lewis Katz School of Medicine Temple University, Philadelphia, Pennsylvania

HIV, anal cancer, and anal cancer screening in Black sub-populations in Miami
Patricia Paule Jeudin, University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida

Panel Discussion 

1:15-1:30 p.m.
Concurrent Sessions 9 & 10
1:30-3 p.m.
Concurrent Session 9: Impact of Comorbidities and Their Treatment on Cancer Biology and Survivorship
Session Chairs: Adana Llanos-Wilson, Mailman School of Public Health, Columbia University, New York, New york, and Julie R. Palmer, Boston University, Boston, Massachusetts

Plasma exosomes as drivers of prostate cancer progression in men with comorbid metabolic disease
Gerald V. Denis, Boston University School of Medicine, Boston, Massachusetts

Obesity and neighborhood redlining: Potential synergism in understanding breast cancer mortality disparities
Lauren E. McCullough, Emory University Rollins School of Public Health, Atlanta, Georgia

Fragmentation of care among Black women who have breast cancer and multiple comorbidities 
Michelle Doose, National Cancer Institute, Rockville, Maryland

Panel Discussion

Concurrent Session 10: Addressing Cancer Health Disparities among Indigenous Communities
Session Chair: Nadine R. Caron, The University of Northern British Columbia, Prince George, BC, Canada

Addressing cancer health disparities among Indigenous communities in Australia 
Gail Garvey, University of Queensland, Brisbane, QLD, Australia

Māori Cancer Leadership Aotearoa New Zealand 
Nina Scott, Waikato DHB, Hamilton, New Zealand
Myra Ruka, Waikato DHB, Hamilton, New Zealand 
Moahuia Goza, Hei Āhuru Mōwai Maori Cancer Leadership Aotearoa, Hamilton, New Zealand 

BC’s joint Indigenous cancer strategy: A history and background 
Warren Clarmont, BC Cancer, Victoria, BC, Canada
Kevin Linn, Harvard University, Boston, Massachusetts

Panel Discussion

3-3:15 p.m.
Hot Topics in Cancer Health Disparities 1 & 2
3:15-5 p.m.
Hot Topics in Health Disparities 1
Session Chair: Salma Kaochar, Baylor College of Medicine, Houston, Texas

Association of Affordable Care Act Medicaid expansions with healthcare access and utilization among people who smoke
Priti Bandi, American Cancer Society, Atlanta, Georgia

Characterization of pseudogene expression and immune infiltration in breast cancer subtypes for African American and Caucasian patients
Eric W. Li, Lakeside School, Seattle, Washington

Neighborhood-level redlining‑associated methylation in breast tumors: The impact of structural racism on the tumor epigenome
Jasmine M. Miller-Kleinhenz, Emory University, Atlanta, Georgia

Association of HER2/GRB7 co-expression with Indigenous American ancestry and breast cancer clinical-pathological features
Laura Rey Vargas, Instituto Nacional de Cancerología, Bogotá, Colombia

Worsening disparities of racial minority participation in phase 1 early drug development trials in the United States, 2001-2018
Hayley M. Dunlop, The Ohio State University College of Medicine, Columbus, Ohio

Examining disparities in incidence of colorectal cancer by race, ethnicity, sex, and site
Andrea Joyce M. Malabay, The University of Texas – MD Anderson Cancer Center, Houston, Texas

Efficacy and safety of darolutamide in Black/African American patients from the phase III ARAMIS trial
Neal Shore, Carolina Urologic Research Center, Myrtle Beach, South Carolina

Hot Topics in Cancer Health Disparities 2
Session Chair: Khadijah A. Mitchell, Lafayette College, Easton, Pennsylvania

Diabetes affects metabolism, redox signaling, DNA repair capacity and mutational burden in breast cancer
Gatikrushna Panigrahi, National Cancer Institute, Bethesda, Maryland

Eligibility criteria perpetuate disparities in enrollment and participation in pancreatic cancer clinical trials
Andrea N. Riner, University of Florida, Gainesville, Florida

Tracking a decade of trends in human papillomavirus (HPV) vaccine hesitancy in the United States
Eric Adjei Boakye, Southern Illinois University School of Medicine, Springfield, Illinois

Blood levels of TNFRSF9 and PTN predict lethal prostate cancer among African American men
Tsion Zewdu. Minas, National Cancer Institute, Bethesda, Maryland

Novel targeted combination therapy to reduce health disparity in high-risk B-cell acute lymphoblastic leukemia in Hispanic/Latino children
Sinisa Dovat, Penn State University College of Medicine, Hershey, Pennsylvania

Potential effect on racial/ethnic disparities of removing racial/ethnic variables from risk models: The example of lung-cancer screening
Corey D. Young, Morehouse School of Medicine, Atlanta, Georgia

MICR Professional Advancement Session: Why I should hire you and why i should retain you
Moderators: John D. Carpten, Keck School of Medicine at USC, Los Angeles, California and Sanya A. Springfield, NCI-CHCRD, Rockville, Maryland
5-6:30 P.M.

Keynote Speaker
Victoria L. Seewaldt, City of Hope Beckman Research Institute, Duarte, California

Tom Misteli, National Cancer Institute Center for Cancer Research, Bethesda, Maryland
Rubin A. Mesa, Mays Cancer Center, San Antonio, Texas

Friday, October 8, 2021

Concurrent Sessions 11 & 12
10-11:30 a.m.
Concurrent Session 11: Pancreatic Cancer and Liver Cancer
Session Chairs: Lewis R. Roberts, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, and Adetunji T. Toriola, Washington University School of Medicine, St. Louis, Missouri

CDKN2A germline rare coding variants and risk of pancreatic cancer in minority populations 
Robert R. McWilliams, Mayo Clinic of Medicine and Science, Rochester, Minnesota

Molecular features contributing to liver carcinogenesis in the Hispanic population
LuZhe Sun, UT Health Science Center at San Antonio, San Antonio, Texas

A pancreatic cancer multidisciplinary clinic reduces socioeconomic disparities in treatment and improves survival
Amer H. Zureikat, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Designing individual-level and structural interventions to reduce and eliminate racial disparities in liver cancer 
Patricia D. Jones, University of Miami Miller School of Medicine, Miami, Florida

Panel Discussion

Concurrent Session 12: Lessons from COVID-19: The Future of Digital Health and Reducing Cancer Disparities
Session Chairs: Vivian J. Bea, Weill Cornell Medicine, New York, New york, and Gezzer Ortega, Brigham & Women’s Hospital, Boston, Massachusetts

Examining clinical trial enrollment, telemedicine, and patient reported outcomes in the COVID-19 era 
Oluwadamilola Fayanju, University of Pennsylvania, Philadelphia, Pennsylvania

Approaching cancer genetic testing and telehealth via health equity lens
Kathie-Ann Joseph, NYU Langone Health, New York, New York

Striving for digital health equity
Jorge A. Rodriguez, Brigham and Women’s Hospital, Boston, Massachusetts

Panel Discussion

11:30-11:45 a.m.
Concurrent Sessions 13 & Hot Topics in Cancer Health Disparities 3
11:45 a.m.-1:15 p.m.
Concurrent Session 13: Impact of Revised Lung and Colorectal Cancer Screening Guidelines in Minority and Native American Communities
Session Chair: Dorothy A. Rhoades, Stephenson Cancer Center, Oklahoma City, Oklahoma  

Disparities in screening for lung cancer: It’s not so black and white
Gerard A. Silvestri, Medical University of South Carolina, Charleston, South Carolina

Lung and colorectal cancer disparities among American Indian and Alaskan Native (AI/AN) populations: A brief overview
Dorothy A. Rhoades, Stephenson Cancer Center, Oklahoma City, Oklahoma

Facilitators and barriers to implementing low-dose CT screening for lung cancer in a tribal health system
Zsolt J. Nagykáldi, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Improving colorectal cancer screening in American Indian and Alaska Native patients
Mark P. Doescher, Stephenson Cancer Center, Oklahoma City, OK

Panel Discussion

Hot Topics in Cancer Health Disparities 3
Session Chair: Ewan K. Cobran, University of Georgia College of Pharmacy, Athens, Georgia

A synergy between the vaginal microbiome and HPV may have explanatory value for racial disparities in risk of pre-cervical cancer
Katherine Y. Tossas, Virginia Commonwealth University, Midlothian, Virginia

Disaggregating Asian American and Pacific Islanders unmasks disparities in survival, time-to-surgery, and surgery-to-radiation intervals among women with Stage I-III breast cancer: An NCDB analysis from 2004-2016
Kekoa Taparra, Stanford Health Care, Stanford, California

Serum prostate-specific antigen levels and prostate cancer risk in a multiethnic population
Alisha Chou, Keck School of Medicine University of Southern California, Los Angeles, California

The role of HMGA2 and CLK3 in prostate cancer health disparities
Taaliah Campbell, Clark Atlanta University, Atlanta, Georgia

Risk prediction model for high-grade squamous intraepithelial lesions in persons living with HIV in Puerto Rico
Marievelisse Soto-Salgado, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

Impact of a cancer health education curriculum among Milwaukee public high school students
Abigail Kerschner, Medical College of Wisconsin, Wauwatosa, Wisconsin

1:15-1:30 p.m.
Plenary Session 2: Forum on Clinical Trial Participation and Underrepresented Populations: Overcoming Barriers and Finding Solutions
Session Chairs: Bettina F. Drake, Washington University Siteman Cancer Center, St. Louis, Missouri, and Jose G. Trevino, Virginia Commonwealth University, Richmond, Virginia
1:30-3 P.M.

If not now, then when? Tackling barriers to clinical trials to ensure inclusion of underrepresented minorities
Vanessa B. Sheppard, VCU Massey Cancer Center, Richmond, Virginia

Improving access to research among individuals from under-represented racial and ethnic minority communities: The Strengthening Research in Diverse Enrollment (STRIDE) study
Stephenie C. Lemon, University of Massachusetts Medical School, Shrewsbury, Massachusetts

A multi-pronged approach to driving diversity in clinical trials: Bristol Myers Squibb and the Bristol Myers Squibb Foundation 
Patricia Doykos, Bristol Myers Squibb, Titusville, New Jersey

Cultural humility in practice: Promoting an inclusive environment for those we serve
Gary L. Ferguson, Washington State University, Seattle, Washington

Title to be announced
Edith P. Mitchell, Jefferson Health Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania 

Panel Discussion

Closing Remarks
3-3:15 p.m.

Melissa B. Davis, Weill Cornell Medicine, New York, New York
Tamara L. Lotan, Johns Hopkins University School of Medicine, Baltimore, Maryland
Camille C. R. Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania  
Jose G. Trevino, Virginia Commonwealth University, Richmond, Virginia